Mon, January 12, 2009
Sun, January 11, 2009
Fri, January 9, 2009
Thu, January 8, 2009
Wed, January 7, 2009
Tue, January 6, 2009
Mon, January 5, 2009
Fri, January 2, 2009
Thu, January 1, 2009
Wed, December 31, 2008
Tue, December 30, 2008
Mon, December 29, 2008
Wed, December 24, 2008
Tue, December 23, 2008
Mon, December 22, 2008
Sun, December 21, 2008
Fri, December 19, 2008
Thu, December 18, 2008

Incyte to Present at the 27th Annual JPMorgan Healthcare Conference


  Copy link into your clipboard //health-fitness.news-articles.net/content/2009/ .. -27th-annual-jpmorgan-healthcare-conference.html
  Print publication without navigation Published in Health and Fitness on , Last Modified on 2009-01-05 13:45:24 by Market Wire


WILMINGTON, Del.--([ BUSINESS WIRE ])--Incyte Corporation (Nasdaq:INCY) announced today it will present at the 27th Annual JPMorgan Healthcare Conference on Tuesday, January 13, 2009 at 3:30 p.m. (Pacific Time) / 6:30 p.m. (Eastern Time).

Paul Friedman, M.D., president and chief executive officer of Incyte, will provide an overview of the company and discuss its most advanced drug discovery and development programs.

The presentation will be webcast live and can be accessed at [ www.incyte.com ] under Investor Relations, Events and Webcasts. A replay of the presentation will be available for 30 days. Investors interested in listening to the live webcast should log on before the start time in order to download any software required.

Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs. Incyte's pipeline includes multiple compounds in Phase I and Phase II development for oncology, inflammation and diabetes.


Publication Contributing Sources

Similar Health and Fitness Publications